Literature DB >> 33402335

Mitochondrial DNA alterations underlie an irreversible shift to aerobic glycolysis in fumarate hydratase-deficient renal cancer.

Daniel R Crooks1, Nunziata Maio2, Martin Lang1, Christopher J Ricketts1, Cathy D Vocke1, Sandeep Gurram1, Sevilay Turan3, Yun-Young Kim1, G Mariah Cawthon1, Ferri Sohelian4, Natalia De Val4, Ruth M Pfeiffer5, Parthav Jailwala6,7, Mayank Tandon6,7, Bao Tran3, Teresa W-M Fan8, Andrew N Lane8, Thomas Ried9, Darawalee Wangsa9, Ashkan A Malayeri10, Maria J Merino11, Youfeng Yang1, Jordan L Meier12, Mark W Ball1, Tracey A Rouault2, Ramaprasad Srinivasan1, W Marston Linehan13.   

Abstract

Understanding the mechanisms of the Warburg shift to aerobic glycolysis is critical to defining the metabolic basis of cancer. Hereditary leiomyomatosis and renal cell carcinoma (HLRCC) is an aggressive cancer characterized by biallelic inactivation of the gene encoding the Krebs cycle enzyme fumarate hydratase, an early shift to aerobic glycolysis, and rapid metastasis. We observed impairment of the mitochondrial respiratory chain in tumors from patients with HLRCC. Biochemical and transcriptomic analyses revealed that respiratory chain dysfunction in the tumors was due to loss of expression of mitochondrial DNA (mtDNA)-encoded subunits of respiratory chain complexes, caused by a marked decrease in mtDNA content and increased mtDNA mutations. We demonstrated that accumulation of fumarate in HLRCC tumors inactivated the core factors responsible for replication and proofreading of mtDNA, leading to loss of respiratory chain components, thereby promoting the shift to aerobic glycolysis and disease progression in this prototypic model of glucose-dependent human cancer.
Copyright © 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Entities:  

Year:  2021        PMID: 33402335      PMCID: PMC8039187          DOI: 10.1126/scisignal.abc4436

Source DB:  PubMed          Journal:  Sci Signal        ISSN: 1945-0877            Impact factor:   8.192


  82 in total

1.  SIFT missense predictions for genomes.

Authors:  Robert Vaser; Swarnaseetha Adusumalli; Sim Ngak Leng; Mile Sikic; Pauline C Ng
Journal:  Nat Protoc       Date:  2015-12-03       Impact factor: 13.491

Review 2.  The metabolic basis of kidney cancer.

Authors:  W Marston Linehan; Christopher J Ricketts
Journal:  Semin Cancer Biol       Date:  2012-06-13       Impact factor: 15.707

3.  Mitochondrial DNA polymerase gamma is essential for mammalian embryogenesis.

Authors:  Nicole Hance; Mats I Ekstrand; Aleksandra Trifunovic
Journal:  Hum Mol Genet       Date:  2005-05-11       Impact factor: 6.150

4.  Significance of 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) for detection of renal cell carcinoma and immunohistochemical glucose transporter 1 (GLUT-1) expression in the cancer.

Authors:  Hideshi Miyakita; Masatosi Tokunaga; Hajime Onda; Yukio Usui; Hidechika Kinoshita; Nobuo Kawamura; Seiei Yasuda
Journal:  Int J Urol       Date:  2002-01       Impact factor: 3.369

5.  Growth Rates of Genetically Defined Renal Tumors: Implications for Active Surveillance and Intervention.

Authors:  Mark W Ball; Julie Y An; Patrick T Gomella; Rabindra Gautam; Christopher J Ricketts; Cathy D Vocke; Laura S Schmidt; Maria J Merino; Ramaprasad Srinivasan; Ashkan A Malayeri; Adam R Metwalli; W Marston Linehan
Journal:  J Clin Oncol       Date:  2020-02-21       Impact factor: 44.544

6.  Human mitochondrial DNA deletions associated with mutations in the gene encoding Twinkle, a phage T7 gene 4-like protein localized in mitochondria.

Authors:  J N Spelbrink; F Y Li; V Tiranti; K Nikali; Q P Yuan; M Tariq; S Wanrooij; N Garrido; G Comi; L Morandi; L Santoro; A Toscano; G M Fabrizi; H Somer; R Croxen; D Beeson; J Poulton; A Suomalainen; H T Jacobs; M Zeviani; C Larsson
Journal:  Nat Genet       Date:  2001-07       Impact factor: 38.330

7.  Predicting the molecular complexity of sequencing libraries.

Authors:  Timothy Daley; Andrew D Smith
Journal:  Nat Methods       Date:  2013-02-24       Impact factor: 28.547

8.  RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome.

Authors:  Bo Li; Colin N Dewey
Journal:  BMC Bioinformatics       Date:  2011-08-04       Impact factor: 3.307

9.  THE METABOLISM OF TUMORS IN THE BODY.

Authors:  O Warburg; F Wind; E Negelein
Journal:  J Gen Physiol       Date:  1927-03-07       Impact factor: 4.086

Review 10.  Oxygen Activation and Energy Conservation by Cytochrome c Oxidase.

Authors:  Mårten Wikström; Klaas Krab; Vivek Sharma
Journal:  Chem Rev       Date:  2018-01-19       Impact factor: 60.622

View more
  13 in total

1.  Genomic and Metabolic Hallmarks of SDH- and FH-deficient Renal Cell Carcinomas.

Authors:  Angela Yoo; Cerise Tang; Mark Zucker; Kelly Fitzgerald; Renzo G DiNatale; Phillip M Rappold; Kate Weiss; Benjamin Freeman; Chung-Han Lee; Nikolaus Schultz; Robert Motzer; Paul Russo; Jonathan Coleman; Victor E Reuter; Ying-Bei Chen; Maria I Carlo; Anthony J Gill; Ritesh R Kotecha; A Ari Hakimi; Ed Reznik
Journal:  Eur Urol Focus       Date:  2022-03-11

Review 2.  A challenging frontier - the genomics and therapeutics of nonclear cell renal cell carcinoma.

Authors:  Hiren V Patel; Arnav Srivastava; Ramaprasad Srinivasan; Eric A Singer
Journal:  Curr Opin Oncol       Date:  2021-05-01       Impact factor: 3.645

3.  Adhesion-mediated mechanosignaling forces mitohormesis.

Authors:  Kevin M Tharp; Ryo Higuchi-Sanabria; Greg A Timblin; Breanna Ford; Carlos Garzon-Coral; Catherine Schneider; Jonathon M Muncie; Connor Stashko; Joseph R Daniele; Andrew S Moore; Phillip A Frankino; Stefan Homentcovschi; Sagar S Manoli; Hao Shao; Alicia L Richards; Kuei-Ho Chen; Johanna Ten Hoeve; Gregory M Ku; Marc Hellerstein; Daniel K Nomura; Karou Saijo; Jason Gestwicki; Alexander R Dunn; Nevan J Krogan; Danielle L Swaney; Andrew Dillin; Valerie M Weaver
Journal:  Cell Metab       Date:  2021-05-20       Impact factor: 31.373

4.  Subgroup-Independent Mapping of Renal Cell Carcinoma-Machine Learning Reveals Prognostic Mitochondrial Gene Signature Beyond Histopathologic Boundaries.

Authors:  André Marquardt; Antonio Giovanni Solimando; Alexander Kerscher; Max Bittrich; Charis Kalogirou; Hubert Kübler; Andreas Rosenwald; Ralf Bargou; Philip Kollmannsberger; Bastian Schilling; Svenja Meierjohann; Markus Krebs
Journal:  Front Oncol       Date:  2021-03-15       Impact factor: 6.244

5.  Hypermethylation of mitochondrial DNA facilitates bone metastasis of renal cell carcinoma.

Authors:  Zheng Liu; Jinhai Tian; Fuhong Peng; Jiang Wang
Journal:  J Cancer       Date:  2022-01-01       Impact factor: 4.207

Review 6.  [FH-deficient renal cell carcinoma expands the spectrum of renal papillary tumors].

Authors:  N Rupp; H Moch
Journal:  Pathologe       Date:  2021-08-27       Impact factor: 1.011

Review 7.  Emerging Role of TCA Cycle-Related Enzymes in Human Diseases.

Authors:  Woojin Kang; Miki Suzuki; Takako Saito; Kenji Miyado
Journal:  Int J Mol Sci       Date:  2021-12-02       Impact factor: 5.923

8.  The spectrum of mitochondrial DNA (mtDNA) mutations in pediatric CNS tumors.

Authors:  Kristiyana Kaneva; Katrina O'Halloran; Petr Triska; Xiyu Liu; Daria Merkurjev; Moiz Bootwalla; Alex Ryutov; Jennifer A Cotter; Dejerianne Ostrow; Jaclyn A Biegel; Xiaowu Gai
Journal:  Neurooncol Adv       Date:  2021-06-02

9.  Increased presence of nuclear DNAJA3 and upregulation of cytosolic STAT1 and of nucleic acid sensors trigger innate immunity in the ClpP-null mouse.

Authors:  Antonia Maletzko; Jana Key; Ilka Wittig; Suzana Gispert; Gabriele Koepf; Júlia Canet-Pons; Sylvia Torres-Odio; A Phillip West; Georg Auburger
Journal:  Neurogenetics       Date:  2021-08-03       Impact factor: 2.660

Review 10.  Personalized Management of Pheochromocytoma and Paraganglioma.

Authors:  Svenja Nölting; Nicole Bechmann; David Taieb; Felix Beuschlein; Martin Fassnacht; Matthias Kroiss; Graeme Eisenhofer; Ashley Grossman; Karel Pacak
Journal:  Endocr Rev       Date:  2022-03-09       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.